{
    "2018-01-05": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Why AbbVie Could See a Big Rise in Its Net Profit Margin in Fiscal 2017",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "net profit margin",
                        "fiscal 2017",
                        "rise"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Spiros Segalas Buys 3 New Stocks in 4th Quarter",
                "features": {
                    "keywords": [
                        "Spiros Segalas",
                        "new stocks",
                        "4th quarter",
                        "buys"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Why AbbVie Is Expected to Report Robust Revenue Growth for 2017",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "robust revenue growth",
                        "2017",
                        "expected"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Will J&J (JNJ) Continue to Tread Growth Path This Year?",
                "features": {
                    "keywords": [
                        "J&J",
                        "growth path",
                        "continue",
                        "tread"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie and Peers: Analyst Recommendations in December",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "peers",
                        "analyst recommendations",
                        "December"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Key Biosimilar Approvals in 2017: Progress Report",
                "features": {
                    "keywords": [
                        "biosimilar approvals",
                        "2017",
                        "progress report"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Biotech: The Tide Is Turning",
                "features": {
                    "keywords": [
                        "biotech",
                        "tide turning"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "3 Large-Cap Pharma Stocks to Watch Out for This New Year",
                "features": {
                    "keywords": [
                        "large-cap pharma stocks",
                        "watch out",
                        "new year"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}